Around 270 people with PNH and 160 people with aHUS will be eligible for the new treatment
News
BMS to pay up to $1.56bn for Agenus’ bispecific antibody programme
BMS will pay Agenus $200m upfront and up to $1.36bn in development, regulatory and commercial milestones
UK trial tests third doses of COVID-19 vaccines
Initial results trialling seven vaccines will inform plans for Autumn booster programme
Janssen inks inflammatory disease collaboration with Mestag Therapeutics
Collaboration will utilise Mestag’s specialist fibroblast subpopulation biology platform to identify novel therapeutic targets
Cross-industry alliance launches to increase awareness of cell and gene therapies in the UK
The Cell & Gene Collective is aiming to advocate for the adoption of next-generation medicine in the UK
NAO report finds UK was ‘not as prepared for pandemic as it could have been’
NHS Confederation chief exec Danny Mortimer said report ‘re-emphasises’ long-term health and social care issues
Oxford Immunotec partners with UK COVID-19 human challenge study
Diagnostic company will provide its T-SPOT Discovery SARS-CoV-2 testing kit to detect T cells in study participants
Positive mid-stage results for Medicago and GSK’s plant-derived COVID-19 vaccine
Plant-derived vaccine candidate showed promising antibody responses against COVID-19 in Phase II study
Merck extends oncology and autoimmunity collaboration with BioMed X
Merck will launch an additional six research projects at the BioMed X Institute on top of its ongoing research projects
Novo Nordisk’s ziltivekimab hits primary endpoint in CKD trial
Investigational IL-6 inhibitor reduced inflammatory biomarkers associated with atherosclerosis in CKD patients
Pandemic coincided with increase in mental health problems for children
New research suggests an association between the COVID-19 pandemic and a ‘sharp’ increase in mental health issues for 11 to 12 years olds
Sanofi, Regeneron’s Dupixent ‘rapidly’ improves lung function in children
Detailed results found Dupixent improved overall asthma control in children aged six to 11 years old
Irish health service hit with ‘significant’ ransomware attack
Minister Ossian Smyth said the attack is “possibly the most significant cybercrime attack on the Irish State”
Biogen’s inherited eye disease gene therapy misses primary endpoint
Company maintained, however, that the study showed ‘positive trends’ across a number of prespecified secondary endpoints
Keytruda wins NICE backing in MSI-H/dMMR colorectal cancer
Immunotherapy recommended for use in patients with MSI/dMMR biomarkers
